Marion Wencker

Exploring the role of CT densitometry: a randomised study of augmentation therapy in α₁-antitrypsin deficiency

Asger Dirksen, Eeva Piitulainen, David Parr et al. · European Respiratory Journal · 2009 · 353 citations · Full text

Health Professions, Clinical Sciences, Pharmacotherapy +14

Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary Disease

Péter Kardos, Marion Wencker, Thomas Glaab et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 315 citations

Pharmacy, Internal Medicine, Pharmacotherapy +16

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group

Niels Seersholm, Marion Wencker, Norbert Banik et al. · European Respiratory Journal · 1997 · 308 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Longitudinal Follow-up of Patients With α1-Protease Inhibitor Deficiency Before and During Therapy With IV α1-Protease Inhibitor

Marion Wencker, B Fuhrmann, N. Konietzko et al. · CHEST Journal · 2001 · 198 citations

Life Sciences, Pharmacotherapy, Immunotherapy +6

Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

Noel G. McElvaney, Jonathan Burdon, Mark Holmes et al. · The Lancet Respiratory Medicine · 2016 · 194 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12